20. Kay S.R, Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 1987; 13 (2): 261-76.
21. Barnes T. R. A rating scale for drug-induced akathisia. The British Journal of Psychiatry. 1989; 154 (5): 672-6.
22. Lohr J.B., Eidt C. A. et al. The clinical challenges of akathisia. CNS Spectrums. 2005; 20 (1): 1-16.
23. Gogman A.G. Alkogolizm, sochetajushhijsja s shizofreniej I zabolevanijami shizofrenicheskogo spectra [Alcoholism combined with schizophrenia and schizophrenic spectrum disorders]. Voprosy narkologii [Narcology issues]. 2014; 3: 127-36. (In Russ)
24. Hartz S.M., Pato C.N., Medeiros H., et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry. 2014; 71 (3): 248-254.
25. Khokhar J.Y., Dwiel L.L., Henricks A.M., et al. The link between schizophrenia and substance use disorder: A unifying hypothesis. Schizophrenia Research. 2017; 194: 78-85.
26. 0stergaard M.L.D., Nordentoft M., Hjorth0j C. Associations between substance use disorders and suicide or suicide attempts in people with mental illness: a Danish nation-wide, prospective, register-based study of patients diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality disorder. Addiction. 2017; 112(7): 1250-9.
27. Schennach-Wolff R., Jдger M., Seemьller F. et al. Outcome of suicidal patients with schizophrenia: results from a naturalistic study. ActaPsychiatrica Scandinavica. 2010; 121 (5): 359-70.
28. Gupta S.K., Jiloha R.C., Yadav A. Onset of schizophrenia at 100 years of age. Indian Journal of Psychiatry. 2014; 56 (1): 82-3.
29. Bertelsen M., Jeppesen P., Petersen L. et al. Suicidal behaviour and mortality in first-episode psychosis: the OPUS trial. The British Journal of Psychiatry. Suppl. 2007; 51: 140-6.
30. Reutfors J., Brandt L., Jцnsson E.G. et al. Risk factors for suicide in schizophrenia: findings from a Swedish population based case- control study. Schizophrenia Research. 2009; 108 (1-3): 231-7.
31. Leucht S., Cipriani A., Spineli L. et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple treatments meta-analysis. The Lancet. 2013; 382 (9896): 951-62.
32. Kasckow J., Felmet K., Zisook S. Managing suicide risk in patients with schizophrenia. CNSDrugs. 2011; 25 (2): 129-43.
33. Leong G.B., Silva J.A. Neuroleptic-induced akathisia and violence: a review. Journal of Forensic Sciences. 2003; 48 (1): 1879.
34. Moller H.J. Occurrence and treatment of depressive comorbidity / cosyndromality in schizophrenic psychoses: conceptual and treatment issues. The World Journal of Biological Psychiatry. 2005; 6 (4): 247-63.
35. Корнетов А.Н., Самохвалов В.П., Корнетов Н.А. Клинико- генетико-антропометрические данные и факторы экзогенной ритмики при шизофрении. Киев: Здоровье, 1984. 158 с.
polar disorder, unipolar depression or personality disorder. Addiction. 2017; 112(7): 1250-9.
27. Schennach-Wolff R., Jдger M., Seemьller F. et al. Outcome of suicidal patients with schizophrenia: results from a naturalistic study. Acta Psychiatrica Scandinavica. 2010; 121 (5): 359-70.
28. Gupta S.K., Jiloha R.C., Yadav A. Onset of schizophrenia at 100 years of age. Indian Journal of Psychiatry. 2014; 56 (1): 82-3.
29. Bertelsen M., Jeppesen P., Petersen L. et al. Suicidal behaviour and mortality in first-episode psychosis: the OPUS trial. The British Journal of Psychiatry. Suppl. 2007; 51: 140-6.
30. Reutfors J., Brandt L., Jцnsson E.G. et al. Risk factors for suicide in schizophrenia: findings from a Swedish population based case- control study. Schizophrenia Research. 2009; 108 (1-3): 231-7.
31. Leucht S., Cipriani A., Spineli L. et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple treatments meta-analysis. The Lancet. 2013; 382 (9896): 951-62.
32. Kasckow J., Felmet K., Zisook S. Managing suicide risk in patients with schizophrenia. CNS Drugs. 2011; 25 (2): 129-43.
33. Leong G.B., Silva J.A. Neuroleptic-induced akathisia and violence: a review. Journal of Forensic Sciences. 2003; 48 (1): 1879.
34. Moller H.J. Occurrence and treatment of depressive comorbidity / cosyndromality in schizophrenic psychoses: conceptual and treatment issues. The World Journal of Biological Psychiatry. 2005; 6 (4): 247-63.
35. Kornetov A.N., Samohvalov V.P., Kornetov N.A. Kliniko- genetiko-antropometricheskie dannye i faktory jekzogennoy rit- miki pri shizoprenii [Clinical, genetic and anthropometric data and factors of exogenous rhythm in schizophrenia]. Kiev: Zdo- rov'e, 1984. 158 s. (In Russ)